The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) \[New York Heart Association (NYHA) Functional Class II or III\].
Cardiomyopathy, Hypertrophic
The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) \[New York Heart Association (NYHA) Functional Class II or III\].
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Local Institution - 0087, West Hollywood, California, United States, 90048-1804
Piedmont Hospital, Atlanta, Georgia, United States, 30309
Local Institution - 0091, Honolulu, Hawaii, United States, 96813-2414
Local Institution - 0093, Boston, Massachusetts, United States, 02114
Local Institution - 0090, Cleveland, Ohio, United States, 44106
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States, 15212-4756
Houston Methodist Hospital, Houston, Texas, United States, 77030
Local Institution - 0035, Murray, Utah, United States, 84107-5701
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Bristol-Myers Squibb,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2026-07-31